Skip to content
If you are a regular reader of Bio.News, you likely know that the past two years have been difficult for the biotech market. Investor […]
As biotech market seeks rebound, economic and political environments are key Read More »
Americans are rightly anxious about the increasing prevalence of serious and deadly infections associated with drug-resistant pathogens – also known as antimicrobial resistance (AMR).
We’re losing the fight against superbugs. The time to act is now. Read More »
Generative artificial intelligence (AI) offers new paths for more effective cancer treatments for patients who are not responding to current options, turning patient and
How we’re expanding cancer treatments with generative AI Read More »
Vitiligo, a chronic autoimmune disorder that causes patches of skin to lose pigment or color, has confounded the medical field for the vast majority
Opzelura goes global Read More »
On Friday, U.S. District Judge Matthew Kacsmaryk in Amarillo, Texas, ordered a hold on federal approval of mifepristone, a drug approved by the U.S.
Texas mifepristone ruling undermines FDA approval process, experts say Read More »
For National Public Health Week, the Biotechnology Innovation Organization (BIO) is talking to Deborah Levine, Director at the City of New York Graduate School
Community involvement is key to effective public health Read More »
The Black Coalition Against COVID (BCAC) was born on Easter Sunday 2020. Dr. Reed Tuckson, the organization’s co-founder recalls, “We looked at the data
On Wednesday, Moderna’s CEO will testify before the Senate Health, Education, Labor, and Pensions (HELP) Committee in a hearing with a misleading title, “Taxpayers
4 questions with Moderna President Stephen Hoge Read More »
The importance of data and the growing use of technology – such as wearables and other mobile devices and sensors that can collect and
How biotech is addressing sources of bias in studies using real-world evidence Read More »
The third anniversary of the COVID-19 pandemic on March 11 may feel to some like a relief as we transition into a post-COVID era.
As the COVID pandemic turns 3, are we ready for the next one? Read More »
